Patent details

EP2887961 Title: NEP INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ATRIAL ENLARGEMENT OR REMODELING

Basic Information

Publication number:
EP2887961
PCT Application Number:
EP2013067472
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP137507257
PCT Publication Number:
WO2014029848
First applicant's nationality:
Translation Language:
EPO Publication Language:
English Title of Invention:
NEP INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ATRIAL ENLARGEMENT OR REMODELING
French Title of Invention:
INHIBITEURS DE NEP POUR LE TRAITEMENT DE MALADIES CARACTÉRISÉES PAR UN AGRANDISSEMENT ATRIAL OU UNE REMODÉLISATION ATRIALE
German Title of Invention:
NEP-INHIBITOREN ZUR BEHANDLUNG VON DURCH VORHOFERWEITERUNG ODER -NEUMODELLIERUNG GEKENNZEICHNETEN KRANKHEITEN
SPC Number:

Dates

Filing date:
22/08/2013
Grant date:
28/04/2021
EP Publication Date:
01/07/2015
PCT Publication Date:
27/02/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/04/2021
EP B1 Publication Date:
28/04/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/08/2021
Expiration date:
22/08/2033
Renunciation date:
Revocation date:
03/09/2022
Annulment date:

Owner

From:
21/04/2021
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
HOLBRO, Thomas
Address:
Switzerland (CH)

2

Name:
SCHUMACHER, Christoph
Address:
Switzerland (CH)

Priority

Priority Number:
201261692911 P
Priority Date:
24/08/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 45/06; A61K 31/4192; A61K 31/216; A61K 31/194; A61K 31/197; A61P 9/00; A61P 9/04; A61P 9/10; A61P 9/06; A61P 43/00; A61P 9/12; A61K 31/41; A61P 7/00;

Publication

European Patent Bulletin

1

Issue number:
202117
Publication date:
28/04/2021
Description:
Grant (B1)

2

Issue number:
202120
Publication date:
19/05/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202209
Publication date:
02/03/2022
Description:
Opposition procedure started

4

Issue number:
202302
Publication date:
11/01/2023
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages